Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity

Abstract

Thus, we showed that L858R receptor mutation in combination with expression of its negative regulator, Mig6, alters signaling outcomes and results in variable drug sensitivity.